Original Research
Published on 05 Dec 2022
Moderators of ayahuasca’s biological antidepressant action
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2022.1033816
- 8,176 views
- 8 citations
Type at least 3 characters
348 articles
Review
Published on 05 Dec 2022
The economics of psychedelic-assisted therapies: A research agenda
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2022.1025726
- 24,909 views
- 28 citations
Review
Published on 02 Dec 2022
Lower-dose psycholytic therapy – A neglected approach
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2022.1020505
- 14,870 views
- 43 citations
Case Report
Published on 01 Dec 2022
Case report: Treatment of psychiatric symptoms for an acromegalic patient with pituitary adenoma
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2022.1068836
- 3,387 views
- 3 citations
Case Report
Published on 01 Dec 2022
Patient with bipolar I disorder who presented with low blood lithium levels after receiving crushed tablets via a nasogastric tube: A case report
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2022.1071721
- 3,720 views
Case Report
Published on 01 Dec 2022
The pathophysiology of rapid fluctuations in mental status associated with olanzapine: A case report
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2022.1028350
- 3,444 views
- 2 citations
Review
Published on 29 Nov 2022
Third-generation antipsychotics in patients with schizophrenia and non-responsivity or intolerance to clozapine regimen: What is the evidence?
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2022.1069432
- 28,018 views
- 21 citations
Original Research
Published on 29 Nov 2022
Reactivations after 5-methoxy-N,N-dimethyltryptamine use in naturalistic settings: An initial exploratory analysis of the phenomenon’s predictors and its emotional valence
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2022.1049643
- 11,107 views
- 16 citations
Original Research
Published on 17 Nov 2022
A survey of drug liking and cravings in patients using sublingual or intranasal ketamine for treatment resistant depression: A preliminary evaluation of real world addictive potential
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2022.1016439
- 5,210 views
- 12 citations
Original Research
Published on 17 Nov 2022
Sexual dysfunction among people with mental illness attending follow-up treatment at a tertiary hospital, Jimma University Medical Center: A cross-sectional study
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2022.999922
- 5,835 views
- 8 citations
Review
Published on 10 Nov 2022
Biology of cyclooxygenase-2: An application in depression therapeutics
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2022.1037588
- 5,953 views
- 23 citations
Systematic Review
Published on 10 Nov 2022
MDMA for the treatment of misophonia, a proposal
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2022.983285
- 16,575 views
- 3 citations
Original Research
Published on 09 Nov 2022
Electroconvulsive therapy for obsessive-compulsive disorder: A retrospective study
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2022.1040443
- 12,148 views
- 6 citations
Original Research
Published on 09 Nov 2022
Use of central nervous system drugs in combination with selective serotonin reuptake inhibitor treatment: A Bayesian screening study for risk of suicidal behavior
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2022.1012650
- 3,226 views
- 2 citations
Case Report
Published on 04 Nov 2022
Acne caused by ziprasidone in a young patient with bipolar disorder: A case report
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2022.948977
- 3,961 views
- 3 citations
Perspective
Published on 03 Nov 2022
Therapeutic setting as an essential component of psychedelic research methodology: Reporting recommendations emerging from clinical trials of 3,4-methylenedioxymethamphetamine for post-traumatic stress disorder
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2022.965641
- 7,135 views
- 15 citations